BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 25394162)

  • 1. APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons.
    Libertone R; Balestra P; Lorenzini P; Pinnetti C; Ricottini M; Menichetti S; Plazzi MM; Giannetti A; Tozzi V; Antinori A; Ammassari A
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19658. PubMed ID: 25394162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals.
    Libertone R; Lorenzini P; Balestra P; Pinnetti C; Ricottini M; Plazzi MM; Menichetti S; Zaccarelli M; Nicastri E; Bellagamba R; Ammassari A; Antinori A
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19655. PubMed ID: 25394159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive disorders in HIV-infected patients: are they HIV-related?
    Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
    AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
    Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores.
    Iacob DG; Luminos M; Benea OE; Tudor AM; Olariu CM; Iacob SA; Ruta S
    Front Med (Lausanne); 2022; 9():888050. PubMed ID: 35966860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis is associated with cognitive impairment in HIV-positive patients.
    Ciccarelli N; Fabbiani M; Grima P; Limiti S; Fanti I; Mondi A; Gagliardini R; D'Avino A; Borghetti A; Cauda R; Di Giambenedetto S
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19722. PubMed ID: 25397468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
    Pissaia A; Borderie D; Bernard D; Scatton O; Calmus Y; Conti F
    Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
    Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
    Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
    Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-invasive fibrosis assessment in chronic hepatitis C: aspartate-aminotransferase to platelet ratio index (APRI) and transient elastography (FibroScan)].
    Pár A; Pár G
    Orv Hetil; 2010 Nov; 151(47):1951-5. PubMed ID: 21071307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
    Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Halfon P
    J Hepatol; 2008 May; 48(5):765-73. PubMed ID: 18314219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
    Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
    Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.
    Hasson H; Merli M; Galli L; Gallotta G; Carbone A; Messina E; Bagaglio S; Morsica G; Salpietro S; Castagna A; Lazzarin A; Uberti-Foppa C
    Liver Int; 2013 Aug; 33(7):1113-20. PubMed ID: 23534616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients.
    Gonzalez EO; Boix V; Deltoro MG; Aldeguer JL; Portilla J; Montero M; Belda EB; Abril V; Gutierrez F; Minguez C; Galindo J; Benirto C; Rodriguez MG; Giner L; Rubio P; Uso J; Llerena G
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19643. PubMed ID: 25394147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.